---
figid: PMC8463267__ga1
figtitle: Combination therapy with miR34a and doxorubicin synergistically inhibits
  Dox-resistant breast cancer progression via down-regulation of Snail through suppressing
  Notch/NFKB and RAS/RAF/MEK/ERK signaling pathway
organisms:
- NA
pmcid: PMC8463267
filename: ga1.jpg
figlink: /pmc/articles/PMC8463267/figure/undfig1/
number: AF1
caption: Figure
papertitle: Combination therapy with miR34a and doxorubicin synergistically inhibits
  Dox-resistant breast cancer progression via down-regulation of Snail through suppressing
  Notch/NF-κB and RAS/RAF/MEK/ERK signaling pathway.
reftext: Xiaoxia Yang, et al. Acta Pharm Sin B. 2021 Sep;11(9):2819-2834.
year: '2021'
doi: 10.1016/j.apsb.2021.06.003
journal_title: Acta Pharmaceutica Sinica. B
journal_nlm_ta: Acta Pharm Sin B
publisher_name: Elsevier
keywords: Breast cancer | miR34a | Dox | Drug resistance | Snail | Notch/NF-κB | RAS/RAF/MEK/ERK
  | Therapy
automl_pathway: 0.9549522
figid_alias: PMC8463267__AF1
figtype: Appendix figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8463267__AF1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8463267__ga1.html
  '@type': Dataset
  description: Figure
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - PARP1
  - COL11A2
  - PARP2
  - PARP3
  - PARP4
  - PARP6
  - PARP8
  - PARP9
  - PARP10
  - PARP11
  - PARP12
  - PARP14
  - PARP15
  - PARP16
  - TNKS
  - TNKS2
  - TIPARP
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - BCL2
  - CD44
  - MIR34A
  - NFKB1
  - KRAS
  - HRAS
  - NRAS
  - SNAI1
  - ITK
  - SLC22A3
  - EPHB2
  - MAPK1
  - MAPK3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MTG1
  - CDH2
  - CDH1
  - FZR1
  - MAP2K7
  - MAP2K1
  - MAP2K2
---
